VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $191 | -21.1% | 14,397 | +11.6% | 0.02% | -21.1% |
Q2 2023 | $242 | +12.6% | 12,898 | -13.6% | 0.02% | +18.8% |
Q1 2023 | $215 | -43.1% | 14,936 | -23.5% | 0.02% | -48.4% |
Q4 2022 | $378 | -99.9% | 19,523 | +58.8% | 0.03% | -20.5% |
Q3 2022 | $422,000 | +99.1% | 12,292 | +32.4% | 0.04% | +457.1% |
Q1 2022 | $212,000 | – | 9,282 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
RA Capital Management | 880,284 | $41,373,000 | 0.57% |
Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |